Zai Lab Announces That Repotrectinib Granted Priority R

SHANGHAI, China and CAMBRIDGE, Mass., May 18, 2023 -- Zai Lab Limited today announced that the Center for Drug Evaluation of China’s National Medical Products Administration has granted... | May 18, 2023

Related Keywords

China , Shanghai , United States , Taiwan , Macau , Hong Kong , Cambridge , Cambridgeshire , United Kingdom , Christine Chiou Lina Zhang , Jennifer Chang Xiaoyu Chen , Rafaelg Amado , Drug Administration , Zai Lab Limited , China National Medical Products Administration , Point Therapeutics Inc , Nasdaq , Drug Registration Regulation Bureau Order , Zai Lab , Bristol Myers Squibb , Head Of Global Oncology Research , Exchange Commission , Zai Lab Forward , Lab Limited , Drug Evaluation , National Medical Products Administration , Global Oncology Research , Drug Registration Regulation , Bureau Order , Working Procedure , Priority Review , Drug Marketing Authorization , Turning Point Therapeutics , Greater China , Mainland China , Breakthrough Therapy Designations , Orphan Drug , Non Small Cell , Lung Cancer , Private Securities Litigation Reform Act , Christine Chiou , Jennifer Chang , Zai Lab Limited Stock Exchange , News , Information , Press Release , End , Bay , 023 , Ai , Lab , Imited , Oday , Nnounced , Hat , The , Center , Or , Drug , Evaluation , F , Ational , Medical , Products , Administration , As Zlab Us98887q1040 ,